PCRX · Pacira BioSciences Inc. Common Stock
View on chartInsiders & Stakes
| Frank D. Lee Chief Executive Officer | ▲ Buy | Grant | 660,831 Shares held | 2/11/2026 | View profile |
| Jonathan Slonin Chief Clinical Officer | ▼ Sell | Open Market | 216,384 Shares held | 8/17/2026 | View profile |
| STACK DAVID M CEO and Chairman | ▲ Buy | Grant | 186,481 Shares held | 6/14/2023 | View profile |
| Kristen Williams Chief Administrative Officer | ▼ Sell | Open Market | 167,062 Shares held | 6/4/2026 | View profile |
| GAUGLER DARYL Chief Operating Officer | ▲ Buy | Grant | 115,443 Shares held | 12/31/2024 | View profile |
| Shawn Cross Chief Financial Officer | ▼ Sell | Open Market | 105,341 Shares held | 4/23/2026 | View profile |
| Brendan Teehan Chief Commercial Officer | ▲ Buy | Grant | 100,934 Shares held | 2/11/2026 | View profile |
| Lauren Riker Senior Vice President, Finance | ▼ Sell | Open Market | 62,284 Shares held | 10/8/2026 | View profile |
| WINSTON ROY Chief Medical Officer | ▼ Sell | Open Market | 52,440 Shares held | 8/2/2023 | View profile |
| Reinhart Charles A. III Chief Financial Officer | ▲ Buy | Grant | 51,867 Shares held | 6/12/2024 | View profile |
| LARANJEIRA CHARLES ANTHONY Chief Technical Officer | ▲ Buy | Option Exercise | 41,752 Shares held | 6/14/2022 | View profile |
| McLoughlin Dennis Chief Customer Officer | ▼ Sell | Open Market | 38,115 Shares held | 6/7/2023 | View profile |
| Mark A. Kronenfeld Director | ▲ Buy | Grant | 34,901 Shares held | 6/11/2025 | View profile |
| Ellis Ronald J. Jr. Chief Strategy Officer | ▼ Sell | Open Market | 30,909 Shares held | 6/7/2023 | View profile |
| Laura Brege Director | ▲ Buy | Grant | 30,120 Shares held | 6/10/2026 | View profile |
| Max Reinhardt President, Rest of World | ▼ Sell | Open Market | 29,225 Shares held | 6/7/2023 | View profile |
| Mark Froimson Director | ▲ Buy | Grant | 26,541 Shares held | 6/10/2026 | View profile |
| Christopher Christie Director | ▲ Buy | Grant | 23,059 Shares held | 6/10/2026 | View profile |
| PACE GARY W Director | ▼ Sell | Open Market | 22,127 Shares held | 3/8/2024 | View profile |
| Michael J. Yang Director | ▲ Buy | Grant | 19,798 Shares held | 6/10/2026 | View profile |
| LONGENECKER JOHN P PHD Director | ▼ Sell | Open Market | 18,823 Shares held | 3/3/2022 | View profile |
| Alethia Young Director | ▲ Buy | Grant | 17,798 Shares held | 6/10/2026 | View profile |
| Marcelo Bigal Director | ▲ Buy | Grant | 17,798 Shares held | 6/10/2026 | View profile |
| Greenstreet Yvonne Chief Executive Officer | ▲ Buy | Grant | 13,247 Shares held | 6/8/2022 | View profile |
| MOLLOY ANTHONY Chief Lgl & Compliance Officer | ▼ Sell | Open Market | 12,877 Shares held | 6/6/2023 | View profile |
| Paul J. Hastings Director | ▼ Sell | Open Market | 12,724 Shares held | 6/13/2024 | View profile |
| Abraham Ceesay Chief Executive Officer | ▼ Sell | Open Market | 9,039 Shares held | 9/4/2025 | View profile |
| Samit Hirawat Director | ▲ Buy | Grant | 6,405 Shares held | 6/10/2026 | View profile |
Transaction History
| Lauren Riker | ▲ Buy | Option Exercise | 6,000 | $194K | 10/8/2026 |
| Lauren Riker | ▼ Sell | Open Market | 6,000 | $218K | 10/8/2026 |
| Jonathan Slonin | ▼ Sell | Open Market | 3,040 | $71K | 8/17/2026 |
| Lauren Riker | ▼ Sell | Open Market | 6,115 | $144K | 6/11/2026 |
| Samit Hirawat | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Christopher Christie | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Alethia Young | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Michael J. Yang | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Marcelo Bigal | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Mark Froimson | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Laura Brege | ▲ Buy | Grant | 6,405 | $0 | 6/10/2026 |
| Kristen Williams | ▼ Sell | Open Market | 10,259 | $228K | 6/4/2026 |
| Lauren Riker | ▼ Sell | Tax Withholding | 3,187 | $71K | 6/3/2026 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 4,728 | $106K | 6/3/2026 |
| Kristen Williams | ▼ Sell | Tax Withholding | 8,528 | $190K | 6/3/2026 |
| Shawn Cross | ▲ Buy | Option Exercise | 12,941 | $213K | 4/23/2026 |
| Shawn Cross | ▼ Sell | Open Market | 12,941 | $326K | 4/23/2026 |
| Shawn Cross | ▲ Buy | Option Exercise | 1,500 | $25K | 4/22/2026 |
| Shawn Cross | ▼ Sell | Open Market | 1,500 | $38K | 4/22/2026 |
| Shawn Cross | ▲ Buy | Option Exercise | 2,845 | $47K | 4/21/2026 |
| Shawn Cross | ▼ Sell | Open Market | 2,845 | $71K | 4/21/2026 |
| Shawn Cross | ▲ Buy | Option Exercise | 7,714 | $127K | 4/20/2026 |
| Shawn Cross | ▼ Sell | Open Market | 7,714 | $194K | 4/20/2026 |
| Jonathan Slonin | ▼ Sell | Open Market | 3,261 | $74K | 3/17/2026 |
| Mark Froimson | ▼ Sell | Open Market | 500 | $11K | 3/17/2026 |
| Shawn Cross | ▲ Buy | Grant | 49,091 | $0 | 2/11/2026 |
| Kristen Williams | ▲ Buy | Grant | 54,546 | $0 | 2/11/2026 |
| Brendan Teehan | ▲ Buy | Grant | 51,714 | $0 | 2/11/2026 |
| Lauren Riker | ▲ Buy | Grant | 19,273 | $0 | 2/11/2026 |
| Jonathan Slonin | ▲ Buy | Grant | 54,546 | $0 | 2/11/2026 |
| Frank D. Lee | ▲ Buy | Grant | 261,818 | $0 | 2/11/2026 |
| Lauren Riker | ▼ Sell | Open Market | 4,000 | $83K | 2/2/2026 |
| Kristen Williams | ▼ Sell | Open Market | 13,137 | $270K | 2/2/2026 |
| Lauren Riker | ▼ Sell | Tax Withholding | 2,751 | $57K | 1/30/2026 |
| Kristen Williams | ▼ Sell | Tax Withholding | 17,134 | $352K | 1/30/2026 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 6,168 | $127K | 1/30/2026 |
| Brendan Teehan | ▼ Sell | Tax Withholding | 5,182 | $106K | 1/30/2026 |
| Frank D. Lee | ▼ Sell | Tax Withholding | 41,488 | $852K | 1/30/2026 |
| Lauren Riker | ▼ Sell | Open Market | 1,416 | $34K | 1/5/2026 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 381 | $9K | 1/2/2026 |
| Lauren Riker | ▼ Sell | Tax Withholding | 159 | $4K | 1/2/2026 |
| Frank D. Lee | ▼ Sell | Tax Withholding | 9,272 | $227K | 1/2/2026 |
| Brendan Teehan | ▲ Buy | Grant | 402 | $4K | 12/31/2025 |
| Shawn Cross | ▲ Buy | Option Exercise | 9,104 | $150K | 12/10/2025 |
| Shawn Cross | ▼ Sell | Open Market | 9,104 | $229K | 12/10/2025 |
| Shawn Cross | ▲ Buy | Option Exercise | 15,896 | $261K | 12/9/2025 |
| Shawn Cross | ▼ Sell | Open Market | 15,896 | $398K | 12/9/2025 |
| Jonathan Slonin | ▼ Sell | Open Market | 3,960 | $95K | 11/17/2025 |
| Shawn Cross | ▼ Sell | Open Market | 12,060 | $266K | 11/10/2025 |
| Shawn Cross | ▼ Sell | Tax Withholding | 6,690 | $143K | 10/31/2025 |
| Abraham Ceesay | ▼ Sell | Open Market | 2,354 | $64K | 9/4/2025 |
| Marcelo Bigal | ▼ Sell | Open Market | 4,912 | $116K | 8/7/2025 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 315 | $7K | 8/1/2025 |
| Mark A. Kronenfeld | ▲ Buy | Grant | 9,999 | $0 | 6/11/2025 |
| Mark Froimson | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Abraham Ceesay | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Marcelo Bigal | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Michael J. Yang | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Christopher Christie | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Alethia Young | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Laura Brege | ▲ Buy | Grant | 6,163 | $0 | 6/11/2025 |
| Lauren Riker | ▼ Sell | Open Market | 5,578 | $146K | 6/4/2025 |
| Kristen Williams | ▼ Sell | Open Market | 14,376 | $377K | 6/4/2025 |
| Lauren Riker | ▼ Sell | Tax Withholding | 3,374 | $89K | 6/3/2025 |
| Kristen Williams | ▼ Sell | Tax Withholding | 6,162 | $163K | 6/3/2025 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 5,084 | $134K | 6/3/2025 |
| Jonathan Slonin | ▲ Buy | Grant | 93,600 | $0 | 2/1/2025 |
| Kristen Williams | ▲ Buy | Grant | 79,200 | $0 | 2/1/2025 |
| Frank D. Lee | ▲ Buy | Grant | 350,000 | $0 | 2/1/2025 |
| Brendan Teehan | ▲ Buy | Grant | 54,000 | $0 | 2/1/2025 |
| Lauren Riker | ▲ Buy | Grant | 30,600 | $0 | 2/1/2025 |
| Jonathan Slonin | ▼ Sell | Open Market | 879 | $16K | 1/6/2025 |
| Frank D. Lee | ▼ Sell | Tax Withholding | 9,375 | $172K | 1/2/2025 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 371 | $7K | 1/2/2025 |
| Lauren Riker | ▼ Sell | Tax Withholding | 159 | $3K | 1/2/2025 |
| GAUGLER DARYL | ▲ Buy | Grant | 244 | $4K | 12/31/2024 |
| GAUGLER DARYL | ▼ Sell | Open Market | 500 | $10K | 12/13/2024 |
| Shawn Cross | ▲ Buy | Grant | 75,000 | $0 | 11/1/2024 |
| GAUGLER DARYL | ▼ Sell | Open Market | 500 | $6K | 9/13/2024 |
| Marcelo Bigal | ▲ Buy | Open Market | 1,512 | $20K | 8/16/2024 |
| Laura Brege | ▲ Buy | Open Market | 1,000 | $13K | 8/16/2024 |
| Michael J. Yang | ▲ Buy | Open Market | 2,000 | $26K | 8/14/2024 |
| Marcelo Bigal | ▲ Buy | Open Market | 3,400 | $41K | 8/12/2024 |
| Frank D. Lee | ▲ Buy | Open Market | 8,264 | $100K | 8/12/2024 |
| Mark Froimson | ▲ Buy | Open Market | 1,400 | $16K | 8/12/2024 |
| Jonathan Slonin | ▼ Sell | Open Market | 945 | $19K | 8/2/2024 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 305 | $6K | 8/1/2024 |
| Jonathan Slonin | ▼ Sell | Open Market | 2,836 | $80K | 7/2/2024 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 914 | $26K | 7/1/2024 |
| GAUGLER DARYL | ▲ Buy | Grant | 160 | $4K | 6/28/2024 |
| Jonathan Slonin | ▲ Buy | Grant | 437 | $11K | 6/28/2024 |
| GAUGLER DARYL | ▼ Sell | Open Market | 1,000 | $28K | 6/13/2024 |
| Paul J. Hastings | ▼ Sell | Open Market | 880 | $25K | 6/13/2024 |
| Kristen Williams | ▼ Sell | Open Market | 7,452 | $211K | 6/13/2024 |
| Lauren Riker | ▲ Buy | Grant | 21,360 | $0 | 6/12/2024 |
| Lauren Riker | ▼ Sell | Open Market | 3,970 | $114K | 6/12/2024 |
| Jonathan Slonin | ▲ Buy | Grant | 54,300 | $0 | 6/12/2024 |
| Christopher Christie | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Marcelo Bigal | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Reinhart Charles A. III | ▲ Buy | Grant | 12,220 | $0 | 6/12/2024 |
| Michael J. Yang | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Abraham Ceesay | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| GAUGLER DARYL | ▲ Buy | Grant | 54,300 | $0 | 6/12/2024 |
| Mark Froimson | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Alethia Young | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Paul J. Hastings | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Kristen Williams | ▲ Buy | Grant | 54,300 | $0 | 6/12/2024 |
| Mark A. Kronenfeld | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Laura Brege | ▲ Buy | Grant | 5,230 | $0 | 6/12/2024 |
| Jonathan Slonin | ▼ Sell | Open Market | 5,012 | $143K | 6/11/2024 |
| Lauren Riker | ▼ Sell | Tax Withholding | 1,843 | $57K | 6/3/2024 |
| Reinhart Charles A. III | ▼ Sell | Tax Withholding | 2,979 | $92K | 6/3/2024 |
| Kristen Williams | ▼ Sell | Tax Withholding | 3,011 | $93K | 6/3/2024 |
| GAUGLER DARYL | ▼ Sell | Tax Withholding | 2,754 | $85K | 6/3/2024 |
| Jonathan Slonin | ▼ Sell | Tax Withholding | 1,615 | $50K | 6/3/2024 |
| PACE GARY W | ▼ Sell | Open Market | 90,000 | $2.8M | 3/8/2024 |
| PACE GARY W | ▼ Sell | Open Market | 28,257 | $871K | 3/7/2024 |
| PACE GARY W | ▼ Sell | Open Market | 1,066 | $32K | 3/6/2024 |
| Kristen Williams | ▲ Buy | Grant | 33,700 | $0 | 2/5/2024 |
| GAUGLER DARYL | ▲ Buy | Grant | 33,700 | $0 | 2/5/2024 |
| Frank D. Lee | ▲ Buy | Grant | 99,520 | $0 | 1/2/2024 |
| Lauren Riker | ▼ Sell | Tax Withholding | 159 | $5K | 1/2/2024 |
| Jonathan Slonin | ▲ Buy | Grant | 5,000 | $0 | 1/2/2024 |
| WINSTON ROY | ▼ Sell | Open Market | 509 | $18K | 8/2/2023 |
| Lauren Riker | ▼ Sell | Open Market | 643 | $25K | 7/5/2023 |
| WINSTON ROY | ▲ Buy | Grant | 10,950 | $0 | 6/14/2023 |
| Kristen Williams | ▲ Buy | Grant | 10,950 | $0 | 6/14/2023 |
| Kristen Williams | ▼ Sell | Open Market | 6,467 | $239K | 6/14/2023 |
| STACK DAVID M | ▲ Buy | Grant | 32,700 | $0 | 6/14/2023 |
| Lauren Riker | ▲ Buy | Grant | 10,000 | $0 | 6/14/2023 |
| Lauren Riker | ▼ Sell | Open Market | 5,773 | $222K | 6/14/2023 |
| Lauren Riker | ▼ Sell | Open Market | 7 | $273 | 6/14/2023 |
| Reinhart Charles A. III | ▲ Buy | Grant | 9,000 | $0 | 6/14/2023 |
| PACE GARY W | ▲ Buy | Grant | 1,775 | $0 | 6/14/2023 |
| Mark A. Kronenfeld | ▲ Buy | Grant | 1,775 | $0 | 6/14/2023 |
| Paul J. Hastings | ▲ Buy | Grant | 1,775 | $0 | 6/14/2023 |
| GAUGLER DARYL | ▲ Buy | Grant | 10,000 | $0 | 6/14/2023 |
| Mark Froimson | ▲ Buy | Grant | 1,775 | $0 | 6/14/2023 |
| Christopher Christie | ▲ Buy | Grant | 1,775 | $0 | 6/14/2023 |
| Laura Brege | ▲ Buy | Grant | 1,775 | $0 | 6/14/2023 |
| Lauren Riker | ▼ Sell | Open Market | 586 | $22K | 6/14/2023 |
| Mark A. Kronenfeld | ▲ Buy | Option Exercise | 15,000 | $449K | 6/8/2023 |
| Mark A. Kronenfeld | ▼ Sell | Open Market | 15,000 | $556K | 6/8/2023 |
| WINSTON ROY | ▼ Sell | Open Market | 1,857 | $70K | 6/7/2023 |
| Kristen Williams | ▼ Sell | Open Market | 1,357 | $51K | 6/7/2023 |
| STACK DAVID M | ▼ Sell | Open Market | 5,326 | $202K | 6/7/2023 |
| Jonathan Slonin | ▼ Sell | Open Market | 490 | $19K | 6/7/2023 |
| Lauren Riker | ▼ Sell | Open Market | 616 | $23K | 6/7/2023 |
| Reinhart Charles A. III | ▼ Sell | Open Market | 1,371 | $52K | 6/7/2023 |
| Max Reinhardt | ▼ Sell | Open Market | 1,099 | $42K | 6/7/2023 |
| McLoughlin Dennis | ▼ Sell | Open Market | 1,057 | $40K | 6/7/2023 |
| GAUGLER DARYL | ▼ Sell | Open Market | 1,047 | $40K | 6/7/2023 |
| Ellis Ronald J. Jr. | ▼ Sell | Open Market | 1,162 | $44K | 6/7/2023 |
| WINSTON ROY | ▼ Sell | Open Market | 1,779 | $69K | 6/6/2023 |
| Kristen Williams | ▼ Sell | Open Market | 1,301 | $51K | 6/6/2023 |
| STACK DAVID M | ▼ Sell | Open Market | 5,058 | $197K | 6/6/2023 |
| Jonathan Slonin | ▼ Sell | Open Market | 471 | $18K | 6/6/2023 |
| Lauren Riker | ▼ Sell | Open Market | 591 | $23K | 6/6/2023 |
| Reinhart Charles A. III | ▼ Sell | Open Market | 1,236 | $48K | 6/6/2023 |
| Max Reinhardt | ▼ Sell | Open Market | 1,054 | $41K | 6/6/2023 |
| MOLLOY ANTHONY | ▼ Sell | Open Market | 4,521 | $174K | 6/6/2023 |
| McLoughlin Dennis | ▼ Sell | Open Market | 1,014 | $40K | 6/6/2023 |
| GAUGLER DARYL | ▼ Sell | Open Market | 1,005 | $39K | 6/6/2023 |
| Ellis Ronald J. Jr. | ▼ Sell | Open Market | 1,114 | $43K | 6/6/2023 |
| MOLLOY ANTHONY | ▼ Sell | Open Market | 2,267 | $87K | 6/5/2023 |
| Paul J. Hastings | ▼ Sell | Open Market | 580 | $22K | 6/5/2023 |
| GAUGLER DARYL | ▼ Sell | Open Market | 1,000 | $39K | 6/5/2023 |
| Laura Brege | ▼ Sell | Open Market | 600 | $23K | 6/5/2023 |
| GAUGLER DARYL | ▲ Buy | Option Exercise | 2,500 | $85K | 5/31/2023 |
| GAUGLER DARYL | ▼ Sell | Open Market | 2,500 | $98K | 5/31/2023 |
| Paul J. Hastings | ▲ Buy | Option Exercise | 7,000 | $209K | 5/15/2023 |
| Paul J. Hastings | ▼ Sell | Open Market | 7,000 | $293K | 5/15/2023 |
| PACE GARY W | ▲ Buy | Option Exercise | 7,000 | $209K | 5/11/2023 |
| PACE GARY W | ▼ Sell | Open Market | 5,015 | $210K | 5/11/2023 |
| Laura Brege | ▲ Buy | Option Exercise | 7,000 | $209K | 4/3/2023 |
| Laura Brege | ▼ Sell | Open Market | 7,000 | $285K | 4/3/2023 |
| MOLLOY ANTHONY | ▼ Sell | Open Market | 546 | $21K | 1/5/2023 |
| MOLLOY ANTHONY | ▼ Sell | Open Market | 158 | $6K | 1/4/2023 |
| Max Reinhardt | ▼ Sell | Open Market | 1,380 | $80K | 10/7/2022 |
| WINSTON ROY | ▼ Sell | Open Market | 476 | $27K | 8/3/2022 |
| Jonathan Slonin | ▼ Sell | Open Market | 308 | $17K | 8/3/2022 |
| Paul J. Hastings | ▼ Sell | Open Market | 533 | $30K | 7/11/2022 |
| Jonathan Slonin | ▼ Sell | Open Market | 924 | $53K | 7/5/2022 |
| LARANJEIRA CHARLES ANTHONY | ▲ Buy | Option Exercise | 6,000 | $230K | 6/14/2022 |
| LARANJEIRA CHARLES ANTHONY | ▲ Buy | Grant | 9,900 | $0 | 6/8/2022 |
| Mark Froimson | ▲ Buy | Grant | 1,160 | $0 | 6/8/2022 |
| STACK DAVID M | ▼ Sell | Open Market | 7,039 | $416K | 6/8/2022 |
| STACK DAVID M | ▼ Sell | Open Market | 5,006 | $302K | 6/8/2022 |
| STACK DAVID M | ▼ Sell | Open Market | 1,282 | $79K | 6/8/2022 |
| STACK DAVID M | ▼ Sell | Open Market | 501 | $31K | 6/8/2022 |
| STACK DAVID M | ▲ Buy | Grant | 21,500 | $0 | 6/8/2022 |
| WINSTON ROY | ▲ Buy | Grant | 9,900 | $0 | 6/8/2022 |
| Kristen Williams | ▲ Buy | Grant | 9,900 | $0 | 6/8/2022 |
| Jonathan Slonin | ▲ Buy | Grant | 9,900 | $0 | 6/8/2022 |
| Lauren Riker | ▲ Buy | Grant | 5,850 | $0 | 6/8/2022 |
| Reinhart Charles A. III | ▲ Buy | Grant | 7,950 | $0 | 6/8/2022 |
| Max Reinhardt | ▲ Buy | Grant | 7,950 | $0 | 6/8/2022 |
| LARANJEIRA CHARLES ANTHONY | ▼ Sell | Open Market | 2,521 | $149K | 6/8/2022 |
| LARANJEIRA CHARLES ANTHONY | ▼ Sell | Open Market | 1,633 | $98K | 6/8/2022 |
| LARANJEIRA CHARLES ANTHONY | ▼ Sell | Open Market | 516 | $31K | 6/8/2022 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Viatris agrees to acquire Pacira BioSciences for $1.65 billion
Viatris has announced plans to acquire Pacira BioSciences for $1.65 billion to expand its non-opioid pain management portfolio. Analysts from RBC and Truist have responded by raising their price targets to $36.50, though Truist downgraded the stock to Hold. The deal is seen as a significant move for Viatris, with RBC noting that a superior bid is unlikely.
Viatris agrees to acquire Pacira BioSciences for $1.65 billion. Viatris has announced plans to acquire Pacira BioSciences for $1.65 billion to expand its non-opioid pain management portfolio. Analysts from RBC and Truist have responded by raising their price targets to $36.50, though Truist downgraded the stock to Hold. The deal is seen as a significant move for Viatris, with RBC noting that a superior bid is unlikely.